58 Biggest Movers From Yesterday

Gainers

• Sienna Biopharmaceuticals Inc SNNA jumped 77.5% to $0.2020 on seemingly no company-specific news.
• Dova Pharmaceuticals, Inc. DOVA shares gained 38.4% to close at $27.95 in reaction to a buyout deal. Dova said Monday it has entered into an agreement to be bought by Swedish Orphan Biovitrum, or SOBI, for $27.50 per share in cash, along with one non-tradeable contingent value right, or CVR, that entitles Dova shareholders to receive an additional $1.50 per share in cash upon regulatory approval of Doptelet.
• Enochian Biosciences Inc. ENOB rose 29.4% to close at $5.50.
• GTT Communications, Inc. GTT gained 20.8% to close at $9.42 as a potential rebound after the stock fell roughly 20% since last Thursday when the stock could not break the $10 resistance level.
• Capricor Therapeutics, Inc. CAPR rose 20.1% to close at $3.70.
• China Customer Relations Centers, Inc. CCRC gained 17.9% to close at $15.99.
• Verrica Pharmaceuticals Inc. VRCA rose 17.9% to close at $14.76.
• Sundial Growers Inc. SNDL gained 16.7% to close at $4.795.
• Thor Industries, Inc. THO gained 15.8% to close at $56.64 after the company reported better-than-expected Q4 EPS results.
• The RealReal, Inc. REAL climbed 15.6% to close at $22.36.
• Jiayin Group Inc. JFIN gained 14.8% to close at $16.69.
• Akero Therapeutics, Inc. AKRO climbed 14.7% to close at $22.75.
• Otonomy, Inc. OTIC gained 12.7% to close at $2.39.
• Seattle Genetics, Inc. SGEN shares rose 12.4% to close at $85.40 after Piper Jaffray maintained an Overweight rating on the stock and raised the price target from $75 to $95. Piper Jaffray raised the price target after Seattle Genetics presented compelling initial data from the EV-103 study, which compares favorably to the current standard of care. It also sees the potential for further upside from additional UBS opportunities.
• SpringWorks Therapeutics, Inc. SWTX gained 12.2% to close at $21.68.
• Contango Oil & Gas Company MCF rose 12.1% to close at $2.78.
• Fastly, Inc. FSLY gained 11% to close at $24.00.
• Idera Pharmaceuticals, Inc. IDRA rose 10.7% to close at $2.89.
• Patrick Industries, Inc. PATK climbed 10.1% to close at $42.88. Patrick Industries completed the acquisition of G.G. Schmitt & Sons, Inc.
• Atreca, Inc. BCEL gained 10.1% to close at $12.24.
• Danaos Corporation DAC climbed 9.8% to close at $9.00.
• ATIF Holdings Limited ATIF gained 9% to close at $3.02.
• Bed Bath & Beyond Inc. BBBY rose 7.6% to close at $10.64. Wedbush upgraded Bed Bath & Beyond from Neutral to Outperform and raised the price target from $14 to $16.
• REGENXBIO Inc. RGNX climbed 6.8% to close at $35.60.
• GreenSky, Inc. GSKY gained 6.7% to close at $6.84.
• Cerus Corporation CERS gained 6.1% to close at $5.16.

Check out these big penny stock gainers and losers

Losers

• Ocugen Inc OCGN shares dipped 70.4% to close at $2.88 on Monday. Ocugen announced the completion of its merger with Histogenics Corporation. Ocugen and CanSinoBIO reported a strategic partnership for gene therapy co-development and manufacturing.
• G1 Therapeutics, Inc. GTHX fell 32.9% to close at $22.78. G1 Therapeutics presented updated data at ESMO 2019 from randomized Phase 2 trial of trilaciclib in combination with chemotherapy in metastatic triple-negative breast cancer demonstrating significant improvement in overall survival at ESMO 2019.
• Adamas Pharmaceuticals, Inc. ADMS fell 23.3% to close at $5.11. Bank of America downgraded Adamas Pharmaceuticals from Neutral to Underperform.
• NanoViricides, Inc. NNVC dipped 21.5% to close at $2.04. NanoViricides filed to raise up to $18.3 million.
• Provention Bio, Inc. PRVB fell 16% to close at $6.82.
• BENITEC BIOPHAR/S ADR BNTC dropped 15.2% to close at $0.7107 after reporting a $2.25 million registered direct offering.
• Lexicon Pharmaceuticals, Inc. LXRX dropped 12.4% to close at $3.01, potentially following a bearish blog post alleging the company does not have enough cash to finish ongoing trials.
• Cal-Maine Foods, Inc. CALM fell 12% to close at $39.96 after the company reported worse-than-expected Q1 EPS and sales results.
• Viveve Medical, Inc. VIVE dropped 12% to close at $4.41.
• Globus Maritime Ltd GLBS shares fell 11.6% to close at $2.05. Globus Maritime reported a Q2 loss of $0.74 per share, versus a year-ago loss of $0.29 per share. Its sales slipped to $3.4 million from $4.194 million.
• FTS International, Inc. FTSI dropped 11.1% to close at $2.24.
• ImmunoGen, Inc. IMGN dipped 11% to close at $2.42 after the company presented data from its unsuccessful FORWARD I study of mirvetuximab. Piper Jaffray analysts noted a change in methodology may have led to the enrollment of patients who did not meet intended threshold.
• Novavax, Inc. NVAX dropped 10.9% to close at $5.02.
• Arcus Biosciences, Inc. RCUS shares declined 10.6% to close at $9.10.
• Pier 1 Imports, Inc. PIR dropped 10.6% to close at $9.72.
• SunCoke Energy, Inc. SXC dipped 10.5% to close at $5.64.
• Teekay LNG Partners L.P. TGP shares fell 9.8% to close at $13.65. Teekay Companies will postpone its investor day originally scheduled on Oct 2 to focus on Teekay LNG.
• Sears Hometown and Outlet Stores, Inc. SHOS dipped 9.7% to close at $3.44.
• BioCryst Pharmaceuticals, Inc. BCRX fell 9.6% to close at $2.8650.
• Stage Stores, Inc. SSI dipped 9.6% to close at $1.88.
• Big 5 Sporting Goods Corporation BGFV fell 9.6% to close at $2.08.
• Endeavour Silver Corp. EXK tumbled 9.4% to close at $2.22.
• Amneal Pharmaceuticals, Inc. AMRX fell 9.4% to close at $2.90.
• Abeona Therapeutics Inc. ABEO dropped 8.1% to close at $2.26.
• Mirati Therapeutics, Inc. MRTX fell 7.7% to close at $77.91.
• Coeur Mining, Inc. CDE fell 7.7% to close at $4.81.
• Immunomedics, Inc. IMMU shares fell 7.4% to close at $13.26 after interim data from the company's phase 2 study of Sacituzumab Govitecan showed a 29 percent response rate.
• Precipio, Inc. PRPO dropped 7.1% to close at $2.61.
• NextCure, Inc. NXTC dropped 5.8% to close at $30.85.
• Precision BioSciences, Inc. DTIL dropped 5.6% to close at $8.39. Precision BioSciences, named Nicholas Riddle, MB, BChir (MD), PhD, as Vice President, Financial Strategy and Investor Relations.
• Teekay Corporation TK fell 5.4% to close at $4.00. Teekay Companies will postpone its investor day originally scheduled on Oct 2 to focus on Teekay LNG.
• Calithera Biosciences, Inc. CALA fell 5% to close at $3.09. Calithera Biosciences announced data from randomized Phase 2 ENTRATA study demonstrate telaglenastat with everolimus improves progression-free survival in renal cell carcinoma at ESMO 2019.